[ad_1]
Extended Diagnostic Test (CG)▶ Click here to enlarge the view
As the government decided to introduce a new diagnostic test method alongside the current genetic amplification test (PCR) to keep up with the spread of the new coronavirus infection (Corona 19), medical insurance will be requested for the ‘test fast antigen ‘from day 14. I decided to do it.
The Security and Disaster Countermeasures Headquarters (middle script) announced that it will provide 50% of the 16,000 won testing cost as medical insurance to be able to actively conduct rapid antigen testing at frontline sites such as emergency rooms, emergency units, intensive care and medical institutions located in vulnerable areas. Sun said. Consequently, the cost to pay for the patient is around 8,000 won.
Unlike general screening clinics where free testing is performed, health insurance will be expanded to reduce the burden of testing costs for nursing facilities in medically vulnerable areas, patients in emergency rooms, and patients in nursing homes. intensive, who had to pay for diagnostic tests.
In addition, private medical institutions that are not covered by health insurance may also undergo examinations for non-payment.
Consequently, even a clinical-grade hospital can perform diagnostic tests with a diagnostic kit.
However, it is reported that there is still debate on whether to extend the application of health insurance to private medical institutions.
Corona 19 test in cold weather tent▶ Click here to enlarge the view
The rapid antigen test is a test method that allows you to check for Corona 19 infection in 30 minutes with a sample collected from inside your nose.
Authorities have remained in the position that they will not use the rapid antigen test for diagnostic tests because the precision is somewhat lower.
However, if the rapid antigen test result is positive, you must perform an additional PCR test to check for infection.
In addition, it is being promoted so that a PCR test based on saliva samples can be performed in medical institutions.
The saliva sample PCR test is the same method as the conventional nasopharyngeal swab PCR test, except that saliva is used instead of the nasopharyngeal sample.
The script explained that the risk of infection due to the spread of saliva droplets is low and the collection of the sample is easy because the patient collects the sample by spitting saliva directly into a separate sample collection container.
In addition, an additional response manpower is added to accelerate epidemiological investigation.
According to the script, 30 central epidemiological investigators belonging to the Korea Centers for Disease Control and Prevention have been assigned to regional disease response centers since the 9th, and 810 staff members to support epidemiological investigations, including military, Police and public officials in training will be sent to public health centers in the metropolitan area, where the spread is strong. be be.
[연합뉴스]
Copyright ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited
